You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
VC biotech funding is decreasing.
"Watson's Folly" is a warning, says Seven Stones blogger.
Nobel laureate Arthur Kornberg dies at 89.
The New York Times points out other Nobel laureates who went off the deep end.
The Economist offers an article on systems biology.
Keith Robison blogs about the second GPCR to be successfully crystallized and have its structure published.
Science reports on decision making, Neandertal's hair and skin, and programmed cell death.
VentureBeat reports on diagnostic firm XDx, which just filed for an IPO.
NAR has a good backgrounder on DNA sequencing from Clyde Hutchison.
Motley Fool has a quick earnings analysis of Illumina.
Nature has American funding problems, Italian bioethics, epigenetic silencing of Ras, and more.
Derek Lowe blogs about pharma layoffs.
James Watson retires from Cold Spring Harbor.
Craig Venter's book is panned by the Washington Post.
An Invitrogen employee is at the center of an article about a family's escape from the California wildfires.
Deepak Singh blogs about the differences between academia and industry.
Blogger Sandra Porter was frustrated in her attempts to teach a bioinformatics class when the computers didn't work.
Genome-wide association studies still going strong -- this time for Alzheimer's.
In two news stories, France authorizes a new DNA test, while the EU authorizes import of the first new GMO products in almost 10 years.
A cartoon a day keeps your funny bone intact.
What are the essential skills every scientist should have? A blogger rounds them up.
Craig Venter is selling synthetic biology to the crowd that never even liked GMO.
US Congress asks NCI to investigate researchers for conflict of interest.
AIDS researchers team up with anti-spam technology to figure out how to predict and guard against rapid mutations in HIV.
A British editorial decries synthetic biology.
Los Angeles brought and settled a civil enforcement action against the makers of an at-home test for SARS-CoV-2, NPR reports.
The Guardian reports that Cancer Research UK is cutting its research funding by £44 million.
Technology Review examines factors affecting SARS-CoV-2 testing turnaround times.
In PNAS this week: mapping of ancient human migrations in Europe, recurrent gene fusion in breast cancer, and more.